|
1
|
Chen Z, Jin Y, Yu D, Wang A, Mahjabeen I,
Wang C, Liu X and Zhou X: Down-regulation of the microRNA-99 family
members in head and neck squamous cell carcinoma. Oral Oncol.
48:686–691. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cai K, Wang Y and Bao X: MiR-106b promotes
cell proliferation via targeting RB in laryngeal carcinoma. J Exp
Clin Cancer Res. 30:732011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fleskens SA, Bergshoeff VE, Voogd AC, van
Velthuysen ML, Bot FJ, Speel EJ, Kremer B, Takes R and Slootweg P:
Interobserver variability of laryngeal mucosal premalignant
lesions: A histopathological evaluation. Mod Pathol. 24:892–898.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Furusaka T, Susaki Y, Saito T, Katsura Y
and Ikeda M: Long-term follow-up and salvage surgery in patients
with T2N0M0 squamous cell carcinoma of the glottic larynx following
concurrent chemoradiation therapy with cisplatin and 5-fluorouracil
for laryngeal preservation. Acta Otolaryngol. 133:91–98. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kimura S, Naganuma S, Susuki D, Hirono Y,
Yamaguchi A, Fujieda S, Sano K and Itoh H: Expression of microRNAs
in squamous cell carcinoma of human head and neck and theesophagus:
miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol
Rep. 23:1625–1633. 2010.PubMed/NCBI
|
|
7
|
Xie L, Qian X and Liu B: MicroRNAs: Novel
biomarkers for gastrointestinal carcinomas. Mol Cell Biochem.
341:291–299. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alencar AJ, Malumbres R, Kozloski GA,
Advani R, Talreja N, Chinichian S, Briones J, Natkunam Y, Sehn LH,
Gascoyne RD, et al: MicroRNAs are independent predictors of outcome
in diffuse large B-cell lymphoma patients treated with R-CHOP. Clin
Cancer Res. 17:4125–4135. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Borel C, Deutsch S, Letourneau A,
Migliavacca E, Montgomery SB, Dimas AS, Vejnar CE, Attar H,
Gagnebin M, Gehrig C, et al: Identification of cis- and
trans-regulatory variation modulating microRNA expression levels in
human fibroblasts. Genome Res. 21:68–73. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Macfarlane LA and Murphy PR: MicroRNA:
Biogenesis, function and role in cancer. Curr Genomics. 11:537–561.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu S, Lu Z, Liu C, Meng Y, Ma Y, Zhao W,
Liu J, Yu J and Chen J: miRNA-96 suppresses KRAS and functions as a
tumor suppressor gene in pancreatic cancer. Cancer Res.
70:6015–6025. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Davidson B, Tropé CG and Reich R: The
clinical and diagnostic role of microRNAs in ovarian carcinoma.
Gynecol Oncol. 133:640–646. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nugent M: MicroRNA function and
dysregulation in bone tumors: The evidence to date. Cancer Manag
Res. 6:15–25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu C, Yu J, Yu S, Lavker RM, Cai L, Liu
W, Yang K, He X and Chen S: MicroRNA-21 acts as an oncomir through
multiple targets in human hepatocellular carcinoma. J Hepatol.
53:98–107. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Kim S and Kim IM: Regulation of
metastasis by microRNAs in ovarian cancer. Front Oncol. 4:1432014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han C, Yu Z, Duan Z and Kan Q: Role of
microRNA-1 in human cancer and its therapeutic potentials. Biomed
Res Int. 2014:4283712014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu X, Wu Y, Liu Y, Deng H, Shen Z, Xiao B
and Guo J: miR-21, miR-106b and miR-375 as novel potential
biomarkers for laryngeal squamous cell carcinoma. Curr Pharm
Biotechnol. 15:503–508. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li W, Ma H and Sun J: MicroRNA-34a/c
function as tumor suppressors in Hep-2 laryngeal carcinoma cells
and may reduce GALNT7 expression. Mol Med Rep. 9:1293–1298.
2014.PubMed/NCBI
|
|
20
|
Yungang W, Xiaoyu L, Pang T, Wenming L and
Pan X: miR-370 targeted FoxM1 functions as a tumor suppressor in
laryngeal squamous cell carcinoma (LSCC). Biomed Pharmacother.
68:149–154. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang T, Liu M, Wang C, Lin C, Sun Y and
Jin D: Down-regulation of MiR-206 promotes proliferation and
invasion of laryngeal cancer by regulating VEGF expression.
Anticancer Res. 31:3859–3863. 2011.PubMed/NCBI
|
|
22
|
Tian L, Li M, Ge J, Guo Y, Sun Y, Liu M
and Xiao H: MiR-203 is downregulated in laryngeal squamous cell
carcinoma and can suppress proliferation and induce apoptosis of
tumours. Tumour Biol. 35:5953–5963. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang HK and Liu HG: Is severe dysplasia
the same lesion as carcinoma in situ? 10-year follow-up of
laryngeal precancerous lesions. Acta Otolaryngol. 2:325–328. 2012.
View Article : Google Scholar
|
|
24
|
Barnes L, Eveson JW, Reichart P and
Sidransky D: World Health Organization Classification of Tumours.
Pathology and Genetics of Head and Neck Tumours. IARC Press.
(Lyon). 10–80. 2001.
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kosaka N, Iguchi H and Ochiya T:
Circulating microRNA in body fluid: A new potential biomarker for
cancer diagnosis and prognosis. Cancer Sci. 101:2087–2092. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cortez MA, Bueso-Ramos C, Ferdin J,
Lopez-Berestein G, Sood AK and Calin GA: MicroRNAs in body fluids -
the mix of hormones and biomarkers. Nat Rev Clin Oncol. 8:467–477.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Taylor DD and Gercel-Taylor C: MicroRNA
signatures of tumor-derived exosomes as diagnostic biomarkers of
ovarian cancer. Gynecol Oncol. 110:13–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu Y, Yang SR, Wang PP, Savas S, Wish T,
Zhao J, Green R, Woods M, Sun Z, Roebothan B, et al: Influence of
pre-diagnostic cigarette smoking on colorectal cancer survival:
Overall and by tumour molecular phenotype. Br J Cancer.
110:1359–1366. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nan H, Giovannucci EL, Wu K, Selhub J,
Paul L, Rosner B, Fuchs CS and Cho E: Pre-diagnostic leukocyte
genomic DNA methylation and the risk of colorectal cancer in women.
PLoS One. 8:e594552013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu L, Ye JX, Qin YZ, Chen QH and Ge LY:
Evaluation of miR-29c, miR-124, miR-135a and miR-148a in predicting
lymph node metastasis and tumor stage of gastric cancer. Int J Clin
Exp Med. 8:22227–22236. 2015.PubMed/NCBI
|
|
32
|
Jiang Q, He M, Ma MT, Wu HZ, Yu ZJ, Guan
S, Jiang LY, Wang Y, Zheng DD, Jin F and Wei MJ: MicroRNA-148a
inhibits breast cancer migration and invasion by directly targeting
WNT-1. Oncol Rep. 35:1425–1432. 2016.PubMed/NCBI
|
|
33
|
Ma L, Xu Z, Xu C and Jiang X:
MicroRNA-148a represents an independent prognostic marker in
bladder cancer. Tumour Biol. Dec 23–2015.[Epub ahead of print].
|
|
34
|
Jung KH, Zhang J, Zhou C, Shen H, Gagea M,
Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK and Beretta L:
Differentiation therapy for hepatocellular carcinoma: Multifaceted
effects of miR-148a on tumor growth and phenotype and liver
fibrosis. Hepatology. 63:864–879. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu T, Qu L, He G, Tian L, Li L, Zhou H,
Jin Q, Ren J, Wang Y, Wang J, et al: Regulation of laryngeal
squamous cell cancer progression by the lncRNA
H19/miR-148a-3p/DNMT1 axis. Oncotarget. 7:11553–11566.
2016.PubMed/NCBI
|
|
36
|
Wu Y, Wang X, Wu F, Huang R, Xue F, Liang
G, Tao M, Cai P and Huang Y: Transcriptome profiling of the cancer,
adjacent non-tumor and distant normal tissues from a colorectal
cancer patient by deep sequencing. PLoS One. 7:e410012012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Clare SE, Pardo I, Mathieson T, Lillemoe
HA, Blosser RJ, Choi M, Sauder CAM, Doxey DK, Badve S, Storniolo
AMV, et al: Abstract P1-03-02: ‘Normal’ tissue adjacent to breast
cancer is not normal. Cancer Res. 72:P103–02. 2012. View Article : Google Scholar
|
